MultiPark: Multidisciplinary research focused on Parkinson´s disease
1401 – 1410 of 3876
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders
(
- Contribution to journal › Article
-
Mark
Dyskinesia matters
(
- Contribution to journal › Article
-
Mark
The catalytic nature of protein aggregation
(
- Contribution to journal › Article
-
Mark
Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies
(
- Contribution to journal › Article
-
Mark
Cerebro-spinal fluid biomarker levels : phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Beta-blocker therapy and risk of vascular dementia : A population-based prospective study
(
- Contribution to journal › Article
-
Mark
Extreme intracranial pressure elevation > 90 mmHg in an awake patient with primary CNS lymphoma—case report
(
- Contribution to journal › Article
-
Mark
Delayed Clinical Manifestation of Parkinson's Disease among Physically Active : Do Participants in a Long-Distance Ski Race Have a Motor Reserve?
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia
(
- Contribution to journal › Article
-
Mark
The dot-compartment revealed? Diffusion MRI with ultra-strong gradients and spherical tensor encoding in the living human brain
(
- Contribution to journal › Article